Site Search:

Home

Open Innovation

Partnerships Asia

Research Store

Investor/Venture Capital

Directory

Events

News

Clinical Trials   Affinium Pharmaceuticals, Ltd., Announces First Patient Dosed with Oral AFN-1252 in a Phase 2 Clinical Trial for Acute Bacterial Skin & Skin Structure Infections PR Newswire   2 Feb 2012 Online System Helps Expedite Clinical Trials in China and Brazil PR Newswire   2 Feb 2012 ThermoGenesis Provides Update on Res-Q® Clinical Evaluations at Leading Stem Cell Therapy Conference PR Newswire   2 Feb 2012 IDRI Supports the First Phase 1 Human Hookworm Vaccine Clinical Trial PR Newswire   1 Feb 2012 Henry Ford Hospital: First in U.S. to Start New Clinical Trial For Innovative Treatment Under Investigation for Aggressive Brain Tumors PR Newswire   1 Feb 2012 NIH to Join Multi-center Clinical Trial of New Tuberculosis Vaccine PR Newswire   1 Feb 2012 HTI-501 Data Support Commencement of Phase 2 Portion of Clinical Trial PR Newswire   1 Feb 2012 Results of NoNO Inc.-Sponsored Phase 2 Clinical Trial in Procedurally-Induced Strokes to be Announced at the International Stroke Conference PR Newswire   31 Jan 2012 Newly-trademarked rED Cap™ Clinical Trials Software Offers Affordable Electronic Data Capture PR Newswire   31 Jan 2012 Pinpoint Genomics Announces Publication of Clinical Study Results using its Pinpoint Dx Lung™ Assay in Lung Cancer PR Newswire   27 Jan 2012

Clinical: Approvals   Mylan Receives Tentative FDA Approval for Generic Version of Lipitor® PR Newswire   2 Feb 2012 Arena Pharmaceuticals Receives Notice from FDA of Advisory Committee Meeting for Lorcaserin PR Newswire   2 Feb 2012 FDA Approves New Skin Cancer Drug First Tested in Arizona by Scottsdale Healthcare and TGen PR Newswire   2 Feb 2012 ThromboGenics Announces That the FDA Intends to Grant Ocriplasmin Priority Review PR Newswire   2 Feb 2012 FDA approves Novartis drug Gleevec® label recommending extending treatment to three years for certain GIST patients after surgery PR Newswire   1 Feb 2012 FDA Approves Gleevec For Expanded Use in Patients With Rare Gastrointestinal Cancer PR Newswire   1 Feb 2012 FDA Approves Kalydeco to Treat Rare Form of Cystic Fibrosis PR Newswire   1 Feb 2012 FDA approves Gleevec for expanded use in patients with rare gastrointestinal cancer FDA   31 Jan 2012 F.D.A. Approves Cystic Fibrosis Drug New York Times   31 Jan 2012 Prescriptions Blog: F.D.A. Approves Drug for an Advanced Skin Cancer New York Times   31 Jan 2012

Clinical: Phase I/II/III   Affinium Pharmaceuticals, Ltd., Announces First Patient Dosed with Oral AFN-1252 in a Phase 2 Clinical Trial for Acute Bacterial Skin & Skin Structure Infections PR Newswire   2 Feb 2012 HTI-501 Data Support Commencement of Phase 2 Portion of Clinical Trial PR Newswire   1 Feb 2012 IDRI Supports the First Phase 1 Human Hookworm Vaccine Clinical Trial PR Newswire   1 Feb 2012 Results of NoNO Inc.-Sponsored Phase 2 Clinical Trial in Procedurally-Induced Strokes to be Announced at the International Stroke Conference PR Newswire   31 Jan 2012 Auxilium Pharmaceuticals, Inc. Announces First Patients Dosed in XIAFLEX® Phase Ib Cellulite Study PR Newswire   26 Jan 2012 Chimerix Announces Presentation of Final Data from CMX001 Phase 2 Trial in Prophylaxis of Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients PR Newswire   25 Jan 2012 Amorcyte, a NeoStem Company, Enrolls First Patient in PreSERVE Phase 2 Trial for Acute Myocardial Infarction PR Newswire   25 Jan 2012 Enlivex Completes Patient Enrollment in its Phase I/II Clinical Trial PR Newswire   25 Jan 2012 immatics Presents Positive Phase II Results With its Therapeutic Cancer Vaccine IMA910 in Patients With Advanced Colorectal Cancer at the 2012 ASCO Gastrointestinal Cancers Symposium PR Newswire   25 Jan 2012 Adeona Announces Initiation of Phase II Clinical Trial of Trimesta™ for Cognitive Dysfunction in Multiple Sclerosis PR Newswire   19 Jan 2012

Using the Site Privacy & Security Statement 
Advertise with us Directory Guide & Access Policy
Event Postings CanBiotech Newsletters

© 2000-2012 CanBiotech™ Inc.